РОЛЬ ТРОМБОЦИТАРНОГО ФАКТОРА РОСТА В ПАТОБИОЛОГИИ ЭПИРЕТИНАЛЬНЫХ МЕМБРАН ПРИ ПРОЛИФЕРАТИВНОЙ ВИТРЕОРЕТИНОПАТИИ (ЭКСПЕРИМЕНТАЛЬНО-МОРФОЛОГИЧЕСКОЕ ИССЛЕДОВАНИЕ)
https://doi.org/10.21516/2072-0076-2016-9-4-59-63
Аннотация
Об авторах
И. П. Хорошилова-МасловаРоссия
Н. Л. Лепарская
Россия
Список литературы
1. Charteris D.G., Sertini C.S., Levis G.P., Fisher S.K. Proliferative vitreoretinopathy - developments in adjunctive treatment and retinal pathology. Eye. 2002; 16: 369-74.
2. Moysidis S., Thanos A., Vavvas D. Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. Hindawy Publishing Corporation. Mediators of inflammation. 2012; Article ID 815937: 11.
3. Morescalchi F., Duse S., Gambicorti E., et al. Proliferative vitreoretinopathy after eye injuries: an over expression of growth factors and cytokines leading to a retinal keloid. Hindawy Publishing Corporation. Mediators of inflammation. 2013. Article JD 269787: 12.
4. Sadaka A., Giuliary G. Proliferative vitreoretinopathy current and emerging treatments. Clinical Ophthalmology. 2012; 6: 1325-33.
5. Lei H., Rheaume M., Kaziauskas A. Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy. Exp Eye Research. 2010; 90(3): 376-81.
6. Li R., Maiminishkis A., Wang F., Miller Sh. PDGF-C and PDGF-D induced proliferation/migration of human RPE is abolished by inflammatory cytokines. Invest Ophthalmol Vis Sci. 2007; 48(12): 5722-32.
7. Leschey K.H., Hines J., Singer J., Hockett S., Compochiaro P. Inhibition of Growth Factor effects in retinal pigment epithelial cells. Investigative Ophthalmology. 1991; 32(6): 1770-8.
8. Leschey K.H., Hockett S., Singer J., Compochiaro P. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1990; 31(5): 839-46.
9. Pennock S., Rheaume M., Mukai Sh., Kaziauskas A. A novel strategy to develop therapeutic approaching to prevent proliferative vitreoretinopathy. American Journal of Pathology. 2011; 179(6): 2931-40.
10. Hiscott P., Hogan S., Heathcote L., et al. Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin and osteonectin (SPAKC). Eye. 2002; 16: 393-403.
Рецензия
Для цитирования:
Хорошилова-Маслова И.П., Лепарская Н.Л. РОЛЬ ТРОМБОЦИТАРНОГО ФАКТОРА РОСТА В ПАТОБИОЛОГИИ ЭПИРЕТИНАЛЬНЫХ МЕМБРАН ПРИ ПРОЛИФЕРАТИВНОЙ ВИТРЕОРЕТИНОПАТИИ (ЭКСПЕРИМЕНТАЛЬНО-МОРФОЛОГИЧЕСКОЕ ИССЛЕДОВАНИЕ). Российский офтальмологический журнал. 2016;9(4):59-63. https://doi.org/10.21516/2072-0076-2016-9-4-59-63
For citation:
Khoroshilova-Maslova I.P., Leparskaya N.L. The role of platelet-derived growth factor in pathobiology of epiretinal membranes in proliferative vitreoretinopathy (an experimental morphological study). Russian Ophthalmological Journal. 2016;9(4):59-63. (In Russ.) https://doi.org/10.21516/2072-0076-2016-9-4-59-63